Neoadjuvant ADT for Asian Patients Undergoing Robotic Radical Prostatectomy Is the Conversation Over?—A Propensity-Matched Comparison
Cancers · 18.02.2026 · 18 (4) · 661
DOI: 10.3390/cancers18040661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.02.2026. Verfasst von John Joson Ng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Duke-NUS Medical School, Singapore 169857, Singapore. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Evidence for neoadjuvant androgen deprivation therapy (ADT) before radical prostatectomy (RP) remains inconclusive, and current guidelines do not endorse its routine use.
Objective
We aimed to evaluate the impact of neoadjuvant ADT on surgical and oncologic outcomes in a Singaporean cohort undergoing radical prostatectomy. Design, setting, and participants: In this retrospective study, 1091 men underwent RP between 2013 and 2024; a total of 105 received neoadjuvant ADT and 986 did not. A 1:1 propensity score-matched analysis was performed on age, PSA, PSA density, Gleason score, clinical T-stage, and receipt of adjuvant therapies, yielding 105 matched pairs. Outcome measurements and statistical analysis: The primary outcome was biochemical recurrence (BCR). Secondary surgical outcomes included operative time, estimated blood loss, length of stay, catheter duration, and postoperative complications. Secondary oncologic outcomes included extracapsular extension, margin status, seminal vesicle invasion, lymph node involvement, clinical-to-pathological T-stage downstaging, Gleason score decrease, and PSA decrease. Kaplan–Meier survival and univariable linear and logistic regression analyses were used. Subgroup analysis was performed using stratified odds ratios to identify clinical subgroups that derived the greatest benefit from neoadjuvant ADT in terms of biochemical recurrence reduction. Results and limitations: After matching, neoadjuvant ADT was associated with a lower rate of extracapsular extension (30.8% vs. 51.4%, p = 0.004), positive surgical margins (18.4% vs. 39.4%, p = 0.002), lymph node involvement (1.0% vs. 13.0%, p = 0.002), and biochemical recurrence (4.8% vs. 18.1%, p = 0.005). There were no significant differences in operative time, blood loss, length of stay, or complication rates. Before matching, 2-year biochemical recurrence-free survival (BCR-FS) did not differ significantly (93.0% vs. 88.2%, log-rank p = 0.26), but after matching, BCR-FS favored ADT (93.0% vs. 81.8%, log-rank p = 0.02). Subgroup analysis showed that the reduction in biochemical recurrence with neoadjuvant ADT was more pronounced in patients with PSA density ≥ 0.20 ng/mL2, Gleason score ≥ 8, and clinical T3 disease. Limitations include the retrospective design and potential residual confounding.
Conclusions
Neoadjuvant ADT prior to RP significantly reduces locoregional spread and biochemical recurrence without increasing perioperative morbidity. Prospective trials are needed to confirm its benefit in high-risk prostate cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke-NUS Medical School, Singapore 169857, Singapore.
- Department of Urology, Singapore General Hospital, Singapore 169608, Singapore.
ORCID-Profile: Kenneth Chen
Zitieren
APA
Ng, J. J., Lim, S., Lee, A., Tan, Y. G., Tay, K. J., Ho, H., Yuen, J., & Chen, K. (2026). Neoadjuvant ADT for Asian Patients Undergoing Robotic Radical Prostatectomy Is the Conversation Over?—A Propensity-Matched Comparison. Cancers, 18(4), 661. https://doi.org/10.3390/cancers18040661
Vancouver
Ng JJ, Lim S, Lee A, Tan YG, Tay KJ, Ho H, et al. Neoadjuvant ADT for Asian Patients Undergoing Robotic Radical Prostatectomy Is the Conversation Over?—A Propensity-Matched Comparison. Cancers. 2026;18(4):661. doi:10.3390/cancers18040661
BibTeX
@article{Ng2026,
author = {Ng, John Joson and Lim, Sean and Lee, Alvin and Tan, Yu Guang and Tay, Kae Jack and Ho, Henry and Yuen, John and Chen, Kenneth},
title = {Neoadjuvant ADT for Asian Patients Undergoing Robotic Radical Prostatectomy Is the Conversation Over?—A Propensity-Matched Comparison},
journal = {Cancers},
year = {2026},
volume = {18},
number = {4},
pages = {661},
doi = {10.3390/cancers18040661}
}
EUVIMED